Vertex to participate in the morgan stanley 21st annual global healthcare conference on september 13

Boston--(business wire)--vertex pharmaceuticals incorporated (nasdaq: vrtx) today announced management participation in the morgan stanley 21st annual global healthcare conference. dr. reshma kewalramani, chief executive officer and president, and charles wagner, executive vice president and chief financial officer, will participate in a fireside chat on wednesday, september 13, 2023 at 11:30 a.m. et. a live webcast of management's remarks will be available through the vertex website, www.vrtx.
VRTX Ratings Summary
VRTX Quant Ranking